Alpha 5 - beta 1 antibodies and their uses

Details for Australian Patent Application No. 2009212442 (hide)

Owner Pfizer Inc. Bristol-Myers Squibb Company

Inventors Chen, Haibin; Brams, Peter; Li, Gang; Hu-Lowe, Dana Dan; Bender, Steven Lee; Toy, Kristopher; North, Michael Aidan; Tanamachi, Dawn M.; Jiang, Xin; Wickman, Grant; Huang, Haichun; Wang, Jianying; Sproul, Tim W.; Yamanaka, Mark; Casperson, Gerald Fries; Yang, Lan; Devaux, Brigitte

Agent Allens Arthur Robinson

Pub. Number AU-A-2009212442

PCT Pub. Number WO2009/100110

Priority 61/095,429 09.09.08 US; 61/026,207 05.02.08 US

Filing date 4 February 2009

Wipo publication date 13 August 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/100110 Priority application(s): WO2009/100110

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009212443-Hydrocarbon-adsorbing porous pavement structure

2009212438-Adaptor for endoscopic orientation of an elongate medical device